A Comparison of the Ocular Hypotensive Efficacy of Twice-Daily 0.25% Levobunolol to 0.5% Timolol in Patients Previously Treated with 0.5% Timolol

Autor: William C. Stewart, Rosanelli Eg, Elaine P. Kelley, Iacono Tl, John C. Lue, Croyle Ta, Alan S. Crandall, Beehler Cc, Ostrov Cs, Macdonald Dk

Publikováno v: Journal of Glaucoma. 1:237-242

Treatment with noncardioselective beta-adrenoceptor antagonists (e.g., 0.5% timolol or 0.5% levobunolol) is standard practice for lowering elevated intraocular pressure (IOP). However, because there are risks and side effects associated with the use

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836b452336cc7a9cea7a98bbb9492d16
https://doi.org/10.1097/00061198-199201040-00005

A comparison of the ocular hypotensive efficacy of twice-daily 0.25% levobunolol to 0.5% timolol in patients previously treated with 0.5% timolol.

Autor: Beehler CC; Private practice, Ft. Myers, Florida; †Medical University of South Carolina, Charleston, South Carolina; ‡University of Utah, Salt Lake City, Utah; §Nalle Clinic, Charlotte, North Carolina; ∥Phillips Eye Institute, Minneapolis, Minnesota; ¶University of South Florida, Tampa, Florida; and # Allergan, Inc., Irvine, California, U.S.A., Stewart WC, Macdonald DK, Croyle TA, Ostrov CS, Rosanelli EG, Crandall AS, Iacono TL, Lue JC, Kelley EP

Publikováno v: Journal of glaucoma [J Glaucoma] 1992 Winter; Vol. 1 (4), pp. 237-42.